1. Deep learning to automatically evaluate HER2 gene amplification status from fluorescence in situ hybridization images
- Author
-
Tian Xue, Heng Chang, Min Ren, Haochen Wang, Yu Yang, Boyang Wang, Lei Lv, Licheng Tang, Chicheng Fu, Qu Fang, Chuan He, Xiaoli Zhu, Xiaoyan Zhou, and Qianming Bai
- Subjects
Medicine ,Science - Abstract
Abstract Human epidermal growth factor receptor 2 (HER2) gene amplification helps identify breast cancer patients who may respond to targeted anti-HER2 therapy. This study aims to develop an automated method for quantifying HER2 fluorescence in situ hybridization (FISH) signals and improve the working efficiency of pathologists. An Aitrox artificial intelligence (AI) model based on deep learning was constructed, and a comparison between the AI model and traditional manual counting was performed. In total, 918 FISH images from 320 consecutive invasive breast cancers were analysed and automatically classified into 5 groups according to the 2018 ASCO/CAP guidelines. The overall classification accuracy was 85.33% (157/184) with a mean average precision of 0.735. In Group 5, the most common group, the consistency was as high as 95.90% (117/122), while the consistency was low in the other groups due to the limited number of cases. The causes of this inconsistency, including clustered HER2 signals, coarse CEP17 signals and some section quality problems, were analysed. The developed AI model is a reliable tool for evaluating HER2 amplification statuses, especially for breast cancer in Group 5; additional cases from multiple centres could further improve the accuracy achieved for other groups.
- Published
- 2023
- Full Text
- View/download PDF